An experimental vaccine against deadly Ebola hemorrhagic fever protected more than 80 percent of mice given a lethal dose of the virus, and may protect humans as well. Unlike previous experimental vaccines, the new vaccine, which is grown in tobacco plants, is also stable enough to stockpile in case of bioterrorism.